Gilead outlines plans to distribute COVID-19 drug worldwide
Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort
Tag: SBECD
Az amerikai gyógyszerhatóság (FDA) engedélyezte a ciklodextrinnel formulázott remdesivir használatát COVID-19 kezelésére
A Gilead Sciences, Inc. amerikai gyógyszercég tegnap bejelentette, hogy a U.S. Food and Drug Administration (FDA, amerikai gyógyszerhatóság) úgynevezett “emergency
SBECD-enabled Remdesivir Receives FDA’s Emergency Use Authorization for the Treatment of COVID-19
Gilead Sciences, Inc. yesterday announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for
Japan to approve remdesivir for coronavirus patients in May
Prime Minister Shinzo Abe said Monday that Japan will soon approve the SBECD-eanbled anti-viral drug remdesivir for the treatment of
Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial
A recently published study from the National Institutes of Health reports on the efficacy of Gilead’s promising antiviral therapy remdesivir
Use of SBECD in kit containing contact lens storage solution
Use of cyclodextrins in contact lens cleaning solutions is dating back to almost thirty years. A patent application was filed
Gilead reports compassionate use data of remdesivir in Covid-19
Gilead Sciences has reported positive data from analysis of an international cohort of patients treated with remdesivir as a potential
Axsome Therapeutics’s SBECD-enabled AXS-07 Achieves Primary Endpoints and Prevents Migraine Pain Progression in Phase 3 Trial
Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced that
EMA’s recommendation on compassionate use of SBECD-enabled remdesivir for COVID-19 and Update from Gilead
During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral
Race to find COVID-19 treatments accelerates
A recent review in Science [1] reported that WHO on 20 March announced the launch of SOLIDARITY, an unprecedented, coordinated